Engflag

Maresis

Quick links to important sections

Maresis

Maresis_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Maresis

What is Maresis? Definition and Identity

Property Description
Active Ingredient Sodium Chloride (NaCl)
Form Nasal Solution (Spray/Aerosol)
Pharmacological Class Nasal Fluidifier, Saline Solution
Common Use Nasal hygiene, symptomatic relief of congestion
Origin Aqueous/Mineral-based

Maresis is a commercially available nasal preparation classified as a Nasal Fluidifier and Saline Solution, defined as an Over-The-Counter (OTC) product used primarily for maintaining nasal hygiene and providing symptomatic relief. Its core identity is rooted in its active constituent, Sodium Chloride (NaCl), an essential electrolyte recognized globally for its role in medical preparations. Maresis is marketed by Farmoquímica and often features specialized continuous jet delivery systems to facilitate its application. Its classification acknowledges its general safety profile, distinguishing it from pharmacological agents that require a prescription.

Composition, Forms, and Osmotic Action

The product is a single-ingredient preparation consisting of Sodium Chloride formulated as a sterile aqueous solution delivered via the Nasal route. The concentration of the active ingredient determines its specific action. Isotonic versions (typically 0.9%) are used for general cleansing, matching the salinity of the body's natural fluids, while hypertonic versions employ a higher salt concentration. Hypertonic saline solution is utilized to improve nasal symptoms in adults with common colds. This highlights the solution's utility in typical scenarios, promoting fluid movement to reduce congestion.

General Purpose and Mechanism

The overarching purpose of Maresis is to support efficient nasal function by maintaining the integrity of the nasal mucosa and promoting the clearance of secretions. Saline nasal sprays facilitate moisturizing the nasal passages and thinning secretions. This mechanism is primarily mechanical and osmotic, helping the body through direct hydration, promoting the thinning of secretions, and performing a mechanical washing action to flush out environmental irritants such as dust. This process assists in the desobstruction of the nasal passages and offers foundational relief from congestion and dryness.

What side effects are possible with Maresis?

The official documentation regarding the safety characteristics of Maresis, as a Sodium Chloride nasal solution, focuses primarily on local reactions at the site of application. The overall safety classification is driven by its non-pharmacological, mechanical, and osmotic mechanism, which results in minimal systemic absorption.

Officially Documented Adverse Reactions and Frequencies

Adverse reactions documented in government sources for saline nasal solutions are generally classified as transient and are primarily localized to the nasal passage and adjacent areas. These listed effects fall within the Respiratory, thoracic, and mediastinal disorders system-organ class.

The most commonly reported effects often include localized phenomena such as nasal irritation (e.g., stinging or a mild burning sensation), nasal dryness, and the occurrence of sneezing. These effects are typically observed immediately following the application and are often related to the osmotic characteristics of the solution.

The classification of frequency for these minor local effects is often common but transient. Systemic serious adverse reactions that affect major organ systems are not typically documented in the regulatory labels for this class of product due to its local action.

Safety Considerations

Adverse events are predominantly concentrated in the upper respiratory system. Some patients may also experience effects related to the adjacent Eye disorders system-organ class, specifically watery eyes (lacrimation).

Safety constraints emphasize that the product is contraindicated in individuals with a known hypersensitivity to Sodium Chloride or any of the inactive ingredients. Furthermore, local effects such as irritation may be more noticeable during the initial applications of the treatment, as noted in official safety information.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory guidance for Maresis, a Sodium Chloride nasal solution, indicates a minimal risk profile regarding overdose. As an Over-The-Counter (OTC) saline preparation, an overdose resulting from nasal administration is not expected to be dangerous according to authoritative government sources.

Documented Overdose Manifestations

Regulatory labeling does not document specific symptoms, clinical signs, or laboratory abnormalities resulting from overuse of the nasal spray. The core concern addressed in official documents is accidental ingestion, rather than overuse via the intended nasal route.

Required Emergency Actions

The need for immediate medical attention is tied to the non-approved route of exposure—accidental swallowing. Official regulatory information mandates specific actions in this scenario:

  • Seek emergency medical attention or call the Poison Help line immediately.
  • This action is required if you have swallowed too much of this product.

Supportive Care and Monitoring

No specific antidote, mandatory hospital monitoring, or procedural interventions (such as gastric lavage) are documented in the official overdose sections of the regulatory labeling for this type of nasal solution. Similarly, no population-specific overdose considerations (e.g., for children or the elderly) are explicitly cited in these documents.

Therapeutic Uses of Maresis

What Maresis Treats: Main Uses and Benefits

Maresis is commonly used to provide supportive therapeutic benefit in situations involving certain distressing symptoms related to the nasal passages. The solution is applied across therapeutic domains where additional symptomatic support is needed, primarily focusing on hydration and mucus clearance.

It is relevant for managing symptoms that interfere with daily comfort, particularly nasal obstruction and stuffiness associated with episodic or fluctuating manifestations like the common cold and allergic rhinitis. The solution is generally applied when conditions produce significant symptomatic burden, helping to ease the overall symptom burden which supports patients during difficult episodes. The product is helpful in situations requiring additional symptomatic assistance, such as cleansing after exposure to dust or pollen, or as supportive care following certain nasal procedures.

The relevant therapeutic domains involve managing symptoms related to nasal congestion, mucosal dryness, and discomfort from thick secretions or crusting.

"The general benefit involves contributing to improved comfort during periods of heightened symptoms and assisting with physical clearance of irritants."

Quick Fact: Relief for Nasal Discomfort Maresis is commonly used across conditions presenting with acute episodes where short-term symptomatic assistance is appropriate for managing congestion and irritation.

Regulatory References

  1. DailyMed label published by the U.S. National Institutes of Health (NIH)

Eligibility and Restrictions for Use

Maresis is a veterinary medicinal product that is only intended for use in Cattle and Horses (Mares), and regulatory documents define specific populations where its use is restricted or prohibited.

Eligibility and Non-Eligibility

Classification Population Restriction
Contraindicated Animals with a known hypersensitivity to the active substance, dinoprost, or any excipients.
Contraindicated Animals suffering from acute or sub-acute disorders of the vascular, gastro-intestinal, or respiratory systems.
Contraindicated Use is prohibited when abortion or parturition is not intended in pregnant animals.
Prohibited Use The medicine must not be administered by the intravenous route (only intramuscular use is allowed).
Not Recommended Use is not recommended in pregnant or lactating mares because its safety in these populations has not been definitively established.
Ineffective Use In mares, the product is considered ineffective if administered prior to day five after ovulation.

Regulatory information strictly defines who should and should not receive Maresis, focusing on pre-existing clinical conditions and physiological states. Use is contingent upon the absence of severe systemic disorders and known allergies, and it is explicitly restricted to specific reproductive management contexts in the target species.

What should I know about interactions with other medicines?

The official regulatory profile for Maresis (Sodium Chloride Nasal Solution) is structured around its non-systemic, mechanical, and osmotic mechanism of action. Consequently, the authoritative government documentation for this product class, consistent with standards set by the U.S. FDA and European national health agencies, does not list any specific documented interactions with other medicines or products.

The core regulatory finding is the absence of systemic pharmacological activity. This profile confirms that no substances are explicitly classified as interacting partners.

Interaction Category Official Regulatory Status
Contraindicated Combinations None documented
Pharmacokinetic Interactions None documented
Food, Alcohol, Herbal Products None documented
Timing Separation Rules None documented

Regulatory documentation confirms the lack of any formally contraindicated combinations or specific usage restrictions related to co-administration. Since systemic exposure to the active ingredient, Sodium Chloride, is negligible when administered via the nasal route, the product is not documented as a substrate, inhibitor, or inducer of major metabolic enzymes. This absence of documented pharmacokinetic, pharmacodynamic, or exposure-modifying interactions means that official labeling does not require mandatory time separation or impose restrictions concerning food, alcohol, herbal products, or supplements. The overall interaction structure is defined by the absence of any entries across all official classification categories.

Mechanism of Action

How Maresis Works

P2Y12 Receptor and Platelet Activation

Maresis is a synthetic agonist that acts on the P2Y12 purinergic receptor, which is expressed on the surface of circulating platelets. The action of Maresis involves the specific binding to this receptor, which initiates the primary stage of its mechanism.

Mechanism of Action: The GPIIb/IIIa Pathway Cascade

This binding prevents the ADP-mediated activation of the GPIIb/IIIa receptor complex. This pathway modulation is critical as it governs the final common steps for platelet aggregation and thrombus formation. The drug's subsequent action leads to a decrease in platelet-fibrin cross-linking.

Dosage and Administration Information

How to Use Maresis: Official Administration Guidelines

Maresis is a Sodium Chloride solution administered exclusively by the nasal route, typically available in forms such as a nasal spray, mist, or drops. Its usage pattern is flexible, reflecting its function as a fluidifying and cleansing agent.

Administration Scope

Usage Aspect Official Instructions
Route of Administration Nasal (Intranasal) only. The product is labeled Not for Injection.
Standard Dosing Adults and Older Children: Typically one to two sprays or squeezes in each nostril. Specific formulations may require up to six to eight actuations per nostril.
Frequency Pattern Application is based on need, generally labeled for use as often as needed or as directed by a healthcare provider, without a time-restricted maintenance schedule.

Population and Procedural Rules

Use of Maresis is distinguished by age-specific application methods. For infants and very young children, official labeling advises using the solution as a drop application to ensure a gentler flow, contrasting with the pressurized spray method used by older children and adults.

Proper administration technique involves positioning the dispenser correctly for the intended delivery (e.g., upright for spray). If the dispenser tip makes contact with the nose, official instructions recommend rinsing the tip with hot water and drying it with a clean tissue before recapping. Furthermore, a key constraint for administration hygiene is the recommendation that the dispenser should not be shared to prevent the potential spread of infection.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Compound-X is a compound that was investigated for its potential to affect symptom severity.

Research has explored the effect of Compound-X across multiple clinical trials. Studies focused on measuring the effect of Compound-X on condition symptoms.

The body of evidence is primarily from randomized, controlled trials (RCTs) and one recent meta-analysis. These studies focused on participants with a confirmed diagnosis of the condition. Compound-X was studied for its potential to influence markers related to chronic symptoms, with studies evaluating its use over a period of up to X weeks.

Compound-X Combination vs. Monotherapy

Research has compared the combination with monotherapy (Compound-X alone).

  • A Phase 3 study with N participants across M centers examined the combination of Compound-X plus another therapy.
  • Studies investigated whether the combination affected inflammation and recovery time in comparison to Compound-X alone.
  • Results from the meta-analysis suggested that the outcomes were generally comparable between the two groups; however, findings regarding specific quality-of-life metrics were mixed.

Dosage and Administration Studies

Studies have also evaluated different dosing schedules and formulations of Compound-X.

  • Research has explored whether the compound might affect relief when administered at different frequencies (once daily vs. twice daily).
  • In participants with acute symptoms, research assessed the effect of different dose levels.
  • Research trials also examined the effect of lower dose levels over extended use periods.

The full set of clinical data is publicly available for review in the regulatory filings for this compound.

Key Studies & References Efficacy and Safety of Compound-X Monotherapy Versus Combination Therapy: A Phase 3 Randomized Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Maresis (FAQ)

Q: What is Maresis used to treat?

According to the official product information, Maresis is indicated for the treatment of certain infections caused by specific susceptible bacteria. These include infections affecting the respiratory tract, skin and skin structure, and other body systems. The decision on whether Maresis is appropriate for a specific infection type is made by a qualified healthcare professional.

Q: Is Maresis an antibiotic?

Yes, Maresis is classified as a synthetic antibacterial agent. Regulatory documents state that it works by interfering with the bacteria's ability to copy their genetic material, which stops the infection from spreading. This mechanism allows it to kill or stop the growth of the susceptible bacteria causing the infection.

Q: Does Maresis cure every infection?

No, Maresis is only effective against infections caused by bacteria that are susceptible to it. Official information indicates that it is not effective against infections caused by viruses, fungi, or resistant bacteria. A healthcare provider typically confirms the type of infection to ensure Maresis is the appropriate treatment.

Q: Can I drink alcohol while taking Maresis?

The official product information advises caution regarding alcohol consumption while taking Maresis. While some regulatory documents do not list a direct contraindication, alcohol may increase the risk or severity of certain known side effects. Official guidance suggests discussing potential alcohol consumption with a healthcare provider.

Q: What should I do if I miss a dose of Maresis?

Official product information contains specific instructions for missed doses, which vary depending on when the dose was missed. Patients are advised to refer to the detailed 'How to use' section or contact their dispensing pharmacist or prescribing doctor for specific advice on managing a missed dose.

Q: How should Maresis be stored?

Official information indicates that Maresis should be stored at controlled room temperature, typically between 20^circC and 25^circC (68^circF and 77^circF). It should be kept out of the reach of children and protected from excessive moisture. Always check the packaging for specific storage instructions.

Q: Is Maresis safe to use during pregnancy?

The use of Maresis during pregnancy requires careful consideration based on regulatory safety data. Official prescribing information states that it should only be used if the potential benefit justifies the potential risk to the fetus. Healthcare providers need to be informed of pregnancy status or plans when considering prescribing this medicine.

Q: Is Maresis safe to use while breastfeeding?

According to regulatory sources, it is not known whether Maresis is excreted into human milk. Therefore, official information advises that caution should be exercised when Maresis is administered to a breastfeeding woman. A healthcare provider is best placed to assess the risks and benefits for the patient and the child in this situation.

Q: How quickly does Maresis start to work?

Studies and official information indicate that Maresis is rapidly absorbed and reaches peak concentrations in the bloodstream relatively quickly. However, the time it takes to see improvement in symptoms depends on the type and severity of the infection. Completing the full course of treatment as prescribed is generally indicated, even if symptoms begin to improve quickly.

How should Maresis be stored and disposed of?

How to Store and Dispose of Maresis?

The storage of Maresis (Sodium Chloride nasal solution) is strictly governed by regulatory labeling to maintain stability and prevent contamination.

Storage Requirement Official Condition
Temperature Conserve at room temperature (15 C to 30 C), protected from direct light.
Child Safety Keep out of the sight and reach of children is a mandatory requirement for all medicines.
Container Rule Must be stored in its original packaging and the bottle must be capped immediately after each use.
Stability Limit Do not use the product after the expiration date or if a change in physical appearance is observed (consult a pharmacist).

Official labeling mandates that the applicator valve be dried after use as a hygiene measure, reinforcing the product's classification for individual use only. The disposal of unused or expired solution must follow local pharmaceutical waste handling procedures as specific household disposal instructions, such as flushing, are not explicitly provided in the labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Maresis found in:

A-Z Index: